M&A TRANSACTION · 2024
Ascend Clinical acquired by Eurofins Scientific
$165.7M· 11.2x EBITDA· 2.20x revenue
Target
Ascend Clinical
Acquirer
Eurofins Scientific
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$76.1M
EBITDA
$14.7M
Deal Value
$165.7M
EV/EBITDA
11.2x
Context
This $165.7M acquisition of Ascend Clinical by Eurofins Scientific sits in the laboratory services sub-vertical. The 11.2x EBITDA multiple paid in 2024 can be compared against the population median for laboratory services transactions of similar size on our Laboratory Services valuation hub. Eurofins Scientific is acquiring as a strategic buyer; see how strategic acquirers typically price laboratory services businesses on our Laboratory Services strategic buyer-pool page.
Source
Data sourced from Press releases and financial statements. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own laboratory services
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Ascend Clinical acquisition.